05 June 2020
BPL is committed to giving regular updates on its key priorities guiding its response to COVID-19.
26 May 2020
"The Fight Is In Us" Campaign Seeks to Mobilize COVID-19 Survivors to Accelerate the Development of Potentially Lifesaving Therapies.
06 May 2020
During the current COVID-19 pandemic, BPL is committed to giving regular updates.
07 April 2020
Participation in a new global alliance of plasma-derived therapeutic companies (including CSL Behring, Takeda, Octapharma, Biotest and LFB) to develop a hyperimmune immunoglobulin product targeting COVID-19.
06 April 2020
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19.
Following the World Health Organisation’s (WHO) declaration that the COVID-19 Coronavirus outbreak is a pandemic, BPL is providing an update on actions taken to date to ensure that health care practitioners and patient needs around the world will continue to be met by the regular supply of our life-enhancing plasma-based products.